###begin article-title 0
Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 277 282 <span type="species:ncbi:9606">human</span>
Protein tyrosine phosphatases (PTPs) like their antagonizing protein tyrosine kinases are key regulators of signal transduction thereby assuring normal control of cellular growth and differentiation. Increasing evidence suggests that mutations in PTP genes are associated with human malignancies. For example, mutational analysis of the tyrosine phosphatase (PTP) gene superfamily uncovered genetic alterations in about 26% of colorectal tumors. Since in these studies tumors have not been stratified according to genetic instability status we hypothesized that colorectal tumors characterized by high-level of microsatellite instability (MSI-H) might show an increased frequency of frameshift mutations in those PTP genes that harbor long mononucleotide repeats in their coding region (cMNR).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
Using bioinformatic analysis we identified 16 PTP candidate genes with long cMNRs that were examined for genetic alterations in 19 MSI-H colon cell lines, 54 MSI-H colorectal cancers, and 17 MSI-H colorectal adenomas. Frameshift mutations were identified only in 6 PTP genes, of which PTPN21 show the highest mutation frequency at all in MSI-H tumors (17%).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Although about 32% of MSI-H tumors showed at least one affected PTP gene, and cMNR mutation rates in PTPN21, PTPRS, and PTPN5 are higher than the mean mutation frequency of MNRs of the same length, mutations within PTP genes do not seem to play a common role in MSI tumorigenesis, since no cMNR mutation frequency reached statistical significance and therefore, failed prediction as a Positive Selective Target Gene.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 559 560 559 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 863 864 863 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1399 1400 1399 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1401 1402 1401 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1403 1405 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Chromosomal instability (CIN) and aneuploidy are molecular features of most sporadic colorectal cancers (~85%) and may confer a worse prognosis [1-3]. About 15% of colorectal cancers (CRC) show microsatellite instability (MSI) due to defective DNA mismatch repair (MMR; [4]). In hereditary non-polyposis colorectal cancer (HNPCC/Lynch syndrome; about 5% of all CRC cases) most of the tumors display this MSI phenotype [5]. As a common molecular theme, MMR-deficient MSI tumors of the colon and other organs accumulate numerous insertion/deletion mutations [6,7] not only at non-coding but also at coding microsatellites (cMS) that cause translational frameshifts and abrogate normal protein function. Such frameshift protein derived neo-peptides can be highly immunogenic and are capable to induce cytotoxic T-cell-mediated killing of MSI-H tumor cells in vitro [8-11]. Frameshift mutations in cMS sequences of a large number of candidate genes have been identified [12-16] and mutations in some of them (TGFBR2, ACVR2, BAX; TCF-4) appear to provide a growth advantage to affected cells [17-20]. Both, sporadic and HNPCC-associated colorectal MSI-H cancers, show distinct clinico-pathological characteristics that include frequent proximal site, diploidy, poor differentiation, less distant metastases, peritumoral lymphocytic infiltrate, comparably good prognosis, and altered chemoresponsiveness [6,7,21-26]. Increasing evidence suggests that cMS mutations in a limited number of target genes appear to be selected for during MSI carcinogenesis and might account for some of these clinico-histopathological features.
###end p 9
###begin p 10
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA </italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 687 697 687 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTP SAP-1 </italic>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 940 947 940 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 1049 1051 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1230 1237 1230 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 1377 1379 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1564 1570 1564 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRJ </italic>
###xml 1601 1603 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1723 1728 1723 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRF</italic>
###xml 1730 1735 1730 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRG</italic>
###xml 1737 1742 1737 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRT</italic>
###xml 1744 1749 1744 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN3</italic>
###xml 1751 1757 1751 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13</italic>
###xml 1759 1765 1759 1765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN14</italic>
###xml 1805 1807 1805 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 662 667 <span type="species:ncbi:9606">human</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
###xml 1414 1420 <span type="species:ncbi:10090">murine</span>
###xml 1558 1563 <span type="species:ncbi:9606">human</span>
###xml 1653 1658 <span type="species:ncbi:9606">human</span>
Protein tyrosine phosphatases (PTPs) like their antagonizing protein tyrosine kinases are key regulators of signal transduction thereby assuring normal control of cellular growth and differentiation [27]. Alterations in the delicate balance between tyrosine phosphorylation and dephosphorylation contribute to the pathogenesis of different inherited or acquired human diseases including autoimmunity, diabetes, and cancer [27-29]. Several studies indicate that mutations in PTP genes may be involved in colorectal carcinogenesis. For example, increased PTPRA mRNA levels have been observed in late stage colorectal tumors [30] and frequent overexpression of the human transmembrane-type PTP SAP-1 may occur relatively late in the adenoma-carcinoma sequence [31]. Expression profiling studies also suggested that PTPs appear to be involved in metastasis of colorectal cancer [32]. In a similar approach, differential expression of the human PTPN21 gene was observed when comparing MSI-H with microsatellite stable (MSS) colorectal cancer cell lines [33] and mutations in this gene were reported to occur in a subset of MSI-H colorectal carcinomas [34]. Additionally, a somatic mutation in the non-receptor PTP Shp2, encoded by the PTPN11 gene, has been detected in a single colon tumor with an increased frequency of somatic alterations, but without microsatellite instability [35]. Moreover, identification of the murine PTP gene Ptprj as a modifier locus conferring susceptibility to colorectal cancer also led to the detection of frequent deletions of the human PTPRJ gene in primary colon cancers [36]. Finally, systematic mutational analysis of the human PTP gene super family identified somatic mutations in six PTPs (PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, PTPN14), affecting 26% of colorectal cancers [37].
###end p 10
###begin p 11
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 203 208 <span type="species:ncbi:9606">human</span>
However, whether coding mononucleotide repeats (cMNR) in PTP genes are specific targets of frameshift mutations in MMR-deficient colorectal tumors is still unknown. In the present study we identified 16 human PTP genes harboring coding region microsatellites and determined their mutation frequencies in MSI-H colorectal tumors. About 32% of MSI-H tumors showed frameshift mutations in any of these PTP genes. However, gene-specific cMNR mutation frequencies did not reach statistical significance according to our recently proposed model for Selective Target Gene prediction [16]. Hence, there is no significant statistical support for a common involvement of any of these PTP genes in MSI colon carcinogenesis.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Cell Lines and Tumor Tissues
###end title 13
###begin p 14
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 533 537 <span type="species:ncbi:9913">calf</span>
###xml 1111 1119 <span type="species:ncbi:9606">patients</span>
Most of the cell lines analyzed in the present study have been described previously [15]. Additional human colorectal cancer cell lines were obtained from Cell Line Services (CLS), Heidelberg, Germany (Colo94H, Colo205, HCT8, SW1116, SW403, T84) or kindly provided by Dr. M. Brattain, University of Texas, Health Science Center, San Antonio, TX (CBS, FET), Dr. J. Wilson, Case Western Reserve University, Cleveland, Ohio (Vaco5, Vaco6, Vaco432, Vaco457), or Dr. I. Fidler (KM12). Cells were grown in RPMI supplemented with 10% fetal calf serum (Life Technologies, Karlsruhe, Germany). Formalin-fixed and Paraffin-embedded tumor and matched normal mucosae samples were treated as described [38]. The MSI status of tumor cell lines (19 MSI-H, 17 MSS), primary colorectal tumors (54 MSI-H and matched normal mucosae), and colorectal adenomas (17 MSI-H, 6 MSS, and matched normal mucosae) has been determined using the NCI/ICG-HNPCC microsatellite marker panel [39] as previously described [38]. Whole blood DNA samples of 60 healthy donors served as additional MSS controls. Informed consent was obtained from all patients and blood donors.
###end p 14
###begin title 15
Candidate cMNR Sequences in PTP Genes
###end title 15
###begin p 16
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
Human PTP genes were sought in our cMNR database ([15] accessible at , MNR_ensembl) that covers all human candidate coding mononucleotide repeats in the entire human genome annotated in the Ensembl database (Ensembl 19.34b, 2004). Candidate cMNRs with repeat length of at least 7 repeat units were considered for further analysis.
###end p 16
###begin title 17
cMNR Instability Analysis
###end title 17
###begin p 18
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Primer design, DNA fragment and data analysis was performed as described [40]. Primer sequences and annealing temperatures are shown in Table 1 [see Additional file 1]. Frameshift mutations were verified by DNA sequence analysis.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
cMNR instability of PTPs in MSI-H colorectal cancer cell lines
###end title 20
###begin p 21
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 653 655 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13 </italic>
###xml 681 688 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 880 887 880 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13 </italic>
###xml 891 897 891 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
A candidate set of 16 PTP genes that contained cMNR sequences composed of at least 7 repeat units were retrieved from our cMNR database (Table 1 [see Additional file 1], MNR_ensembl is accessible at ). Using DNA fragment analysis we examined cMNR length alterations of these candidate genes in 19 MSI-H and 17 MSS colorectal cancer cell lines. cMNR frameshift mutations occurred exclusively in MSI-H colorectal cancer cell lines and affected four PTP genes (Tables 2 and 4 [see Additional file 1]; PTPN21, PTPN13, PTPRS, PTPN23). Results of fragment analysis are exemplarily shown in figure 1. The highest mutation frequencies were associated with the A8 cMNRs in PTPN13 (22%) and PTPN21 (26%). All mutations occurred in a heterozygous state and predominantly represented single nucleotide deletions (minus 1 allele, n = 10). Two were single nucleotide insertions (plus 1 allele, PTPN13 and PTPN21). No larger shifts could be detected. Overall, the larger fraction of MSI-H colorectal cancer cell lines (63%; 12/19) showed frameshift mutations in any of the four affected PTP genes.
###end p 21
###begin p 22
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electropherograms of allelic shifts</bold>
Electropherograms of allelic shifts. Electropherograms of shifted alleles. DNA fragment analysis of a representative set of PTP cMNRs in a MSI-H colorectal tumor (KS2966A, Sam49) and MSI-H cancer cell lines (Co115, TC71, and HCT116). Corresponding wildtype alleles (wt, lower panel) are indicated together with tumor cell-specific allelic shifts marked by asterisks (upper panel). Allele intensities were determined (peak area) and ratios (f) of wildtype and novel alleles in primary tumors and cell lines were calculated, defining a 2-fold difference as threshold for allelic shifts.
###end p 22
###begin title 23
PTP cMNR Mutations in MSI-H Primary Colorectal Carcinomas
###end title 23
###begin p 24
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRE</italic>
###xml 298 304 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRE</italic>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 695 697 695 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 707 714 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13 </italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1024 1029 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 1031 1036 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 1038 1043 1038 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRE</italic>
###xml 1155 1156 1155 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1591 1592 1591 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
We next analyzed the same set of 16 PTP genes for cMNR frameshift mutations in 54 MSI-H colorectal carcinomas and adjacent normal mucosa. Frameshift mutations in these primary tumors were identified in 6 PTP genes (PTPN21, PTPRS, PTPN5, PTPN23, PTPRA, PTPRE) comprising mutation targets shared by (PTPN21, PTPRS, PTPN23) or different from (PTPN5, PTPRA, PTPRE) those in the MSI-H cell lines (Tables 3 and 4 [see Additional file 1], Figure 1). In MSS mucosa samples such changes almost never occurred (1/703 analyses). Two genes, PTPN21 and PTPRS, were most frequently affected in primary colorectal tumors (16% and 12%, respectively). However, primary tumors lacked frameshift mutations in the A8 repeat of PTPN13 and thus appeared to arise only in cultured MSI-H CRC cell lines. Since LS174T and LS180 are derived from the same primary tumor [41,42] and the overall mutation frequency is quite low it is very likely that this mutation already manifested within the primary tumor. Vice versa, mutations in three other PTPs (PTPN5, PTPRA, PTPRE) remained restricted to primary tumors and occurred at very low frequency (Tables 3 and 4 [see Additional file 1]). Overall, frameshift mutations in any of these 6 PTP genes were observed in 32% of MSI-H tumors. The most common type of mutation were single nucleotide deletions (16/21, 76%) and all frameshift mutations appeared to affect only one allele (heterozygous). Interestingly, all PTP mutations are located within or upstream of the phosphatase domains and hence are expected to impair or completely abrogate phosphatase activity (Figure 2).
###end p 24
###begin p 25
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Domain structure of selected PTPs and sites of cMNR frameshift mutations</bold>
Domain structure of selected PTPs and sites of cMNR frameshift mutations. Structure of PTP proteins. Tyrosine phosphatase domains (PTPc) as well as frameshift mutation sites (arrowhead, stippled lines) are indicated. Remaining domain abbreviations: IG immunoglobulin like domain, FN fibronectin type 3 domain, KIND kinase non-catalytic C-lobe domain, ERM ezrin/radixin/moesin domain, PDZ Domain present in PSD-95, Dlg, and ZO-1/2., BRO1 BRO1-like domain, TM transmembrane domain. Despite PTPN5 is a non-receptor phosphatase there is a TM domain annotated within Ensembl.
###end p 25
###begin title 26
PTPN21 cMNR Mutations in MSI-H Colorectal Adenomas
###end title 26
###begin p 27
###xml 24 26 24 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Since mutations in the A8 coding repeat of PTPN21 were the most frequent genetic alterations shared by MSI-H cancer cell lines and primary tumors we also analyzed this coding repeat in 17 MSI-H and 6 MSS colorectal adenoma samples. As expected, no cMNR frameshift mutations were detected in the MSS adenomas. However, in 2 of 17 MSI-H adenomas we identified deletion and insertion mutations (Table 4 [see Additional file 1], Figure 1). These results rather argue for an early event during MSI colorectal carcinogenesis.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 632 638 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 640 645 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 647 652 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 654 660 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 662 667 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 669 674 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRE</italic>
###xml 851 853 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1127 1133 1125 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 1135 1141 1133 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 1143 1148 1141 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 1150 1155 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 1157 1163 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRE </italic>
###xml 1167 1173 1165 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS </italic>
###xml 1232 1237 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRF</italic>
###xml 1239 1244 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRG</italic>
###xml 1246 1251 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRT</italic>
###xml 1253 1258 1251 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN3</italic>
###xml 1260 1266 1258 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13</italic>
###xml 1272 1278 1270 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN14</italic>
###xml 2005 2007 2003 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2145 2151 2143 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN13</italic>
###xml 422 427 <span type="species:ncbi:9606">human</span>
###xml 2317 2322 <span type="species:ncbi:9606">human</span>
###xml 2336 2341 <span type="species:ncbi:9606">human</span>
The goal of this study was to determine type, frequency, and pattern of cMNR frameshift mutations in protein PTP genes in MSI-H colorectal cancer cell lines and primary colon tumors. This gene family was selected because PTPs are expected to exert tumor suppressive function and thus represent potential targets of inactivating mutations in DNA mismatch repair deficient tumors. Among the large number of PTP genes in the human genome we selected 16 PTP genes that contained coding region microsatellites of increased length (>/= 7 repetitive units). Our results provide evidence for frameshift mutations in six of these PTP genes (PTPN21, PTPRS, PTPN5, PTPN23, PTPRA, PTPRE) affecting about 32% of MSI-H colorectal cancers. This frequency differs slightly from a previous study that reported PTP mutations in 26% of unselected colorectal carcinomas [37]. Although most of the coding repeat-harboring PTP genes (13/16 candidates) analyzed by us have also been examined by Wang and co-workers, different sets of mutated PTP genes were identified in both studies. In particular, we observed tumor-specific genetic alterations in PTPN21, PTPN23, PTPN5, PTPRA, PTPRE and PTPRS whereas mutations reported by Wang et al. were confined to PTPRF, PTPRG, PTPRT, PTPN3, PTPN13, and PTPN14. This difference most probably can be explained by the different screening strategies used in these two studies. Wang et al. performed their initial mutational pre-screening on a set of 18 unselected colorectal tumors, This subset would be expected to include only 2 to 3 MSI tumors based on a general MSI frequency of 15% reported for unselected colorectal cancers. Since the type of mutation and the spectrum of affected genes is remarkably different among MSS and MSI-H tumors, the observed differences are not unexpected. However, there were also some consistent findings in both studies. For example, PTPN13 was examined by both groups but no cMNR mutations were observed in a cumulative number of 69 MSI-H CRC samples ([43] and data presented here). Interestingly, Wang et al. described two nonsense or frameshift mutations at the expected MNR position within PTPN13. Unfortunately, any information about the MSI status of these tumors is missing. So, our investigation represent a reasonable completion of a systematic analysis of human PTP genes in human colorectal cancers.
###end p 29
###begin p 30
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 676 683 676 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 685 686 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 689 695 689 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS </italic>
###xml 697 698 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 701 707 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5 </italic>
###xml 709 710 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 814 821 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 822 824 822 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8 </sub>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1409 1412 1409 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fas</italic>
###xml 1414 1420 1414 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apaf-1</italic>
###xml 1426 1433 1426 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bcl-10 </italic>
###xml 1434 1436 1434 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1947 1954 1947 1954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 1718 1723 <span type="species:ncbi:9606">human</span>
Recently, we proposed a statistical model that allows to predict positively or negatively selected target genes of MSI tumorigenesis in an organ-specific manner based on cMNR mutation frequencies [16]. According to the actual release of this model (, release 200711), cMNRs of 7 or 8 repetitive units - in the absence of any biological selection pressure - are expected to show a mean somatic mutation rate of about 4% and 9% respectively. In order to qualify as positively selected MSI target genes, tumor-specific mutation frequencies for cMNRs of this length have to exceed 22% and 28%, respectively. The three most frequently mutated PTPs identified in the present study (PTPN21 [A8], PTPRS [C7], PTPN5 [C7]) show mutation frequencies of 17%, 12%, and 6%, respectively. The final overall mutation frequency of PTPN21 A8 (14.4%) is even slightly lower, when considering data from the literature [14]. Certainly, we did not extend our mutation search to the entire coding sequence of each PTP gene, and therefore, additional mutations outside the cMNR sequence cannot be excluded. Furthermore, detailed studies of individual tumor types have provided compelling evidence that mutations of different genes but within the same pathway can have similar functional effects, i.e. leading to its disruption and providing a growth advantage to affected cells [37], as it has been proposed for apoptotic genes like Fas, Apaf-1, and Bcl-10 [44]. In conclusion, although these gene-specific mutation rates are higher than the mean mutation frequencies for this length of repeats they do not reach statistical significance and prediction about positive Selective Target Genes in MSI-H tumorigenesis is not feasible. Therefore, human PTP genes do not seem to play a common role in MSI-H tumorigenesis. However, contribution to individual tumor development cannot be excluded. Furthermore, the observation of 2 mutations within a set of 17 MSI-H adenomas in PTPN21 argues for an early event in malignant transformation.
###end p 30
###begin p 31
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN23</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN5</italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRS</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPRA</italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 946 952 <span type="species:ncbi:10090">murine</span>
Despite some structural diversity, the six PTP proteins found to be mutated in the present study share a catalytically active phosphatase that resides in one (PTPN21, PTPN23, PTPN5, PTPRS) or two (PTPRA) C-terminal domains [45]. Notably, all cMNR frameshift mutation sites are located upstream or within the first half of these catalytic domains (see Figure 2) resulting in truncated proteins that are expected to show partial or complete loss of phosphatase activity. However, all PTP frameshift mutations only affected a single allele leaving the cMNR on the remaining allele intact. The presence of contaminating normal inflammatory cells in these tumors may well account for this observation. Alternatively, the remaining wildtype copy may be silenced by epigenetic mechanisms. The absence of biallelic mutations in the analyzed tumors could be due to a dominant negative fashion or affection of gene dosage [46,47]. Shortened transcripts of murine PTPs lacking catalytic or interaction domains by alternative splicing can act in a dominant negative manner [48].
###end p 31
###begin p 32
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 249 256 249 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21 </italic>
From our analysis of preneoplastic lesions we further conclude that PTPN21 frameshift mutations also occur in MSI-H colorectal adenomas albeit at lower frequency (12%) thereby indicating an early step during MSI tumorigenesis. At the protein level, PTPN21 is known to bind to and activate c-Src and Etk protein kinases [49,50]. Interestingly, activated Etk has been reported to trigger apoptosis in breast cancer cells via Stat1 and p21 [51]. By analogy, we hypothesize that inactivation of PTPN21 by cMNR frameshift mutations in MSI-H colon cancer cells might lead to Etk inactivation and subsequent inhibition of apoptosis.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 437 442 <span type="species:ncbi:9606">Human</span>
The work presented here shows a systematic investigation using an evidence based approach: cMNRs of human PTP genes with the highest chance for mutational events in MSI-H colorectal tumors were selected. Although we observed a similar overall mutation frequency in MSI colorectal cancers compared to the results reported by Wang et al. for unselected colorectal cancers, a different set of PTP genes appears to be mutated in MSI tumors. Human PTP genes identified in the present study seem to play no common role in the tumorigenesis of MSI-H tumors, supported by statistical considerations. However, within individual MSI-H carcinogenesis such mutations could have had impact to malignant transformation, but so far no functional data exist that could confirm this hypothesis.
###end p 34
###begin title 35
Competing interests
###end title 35
###begin p 36
The authors declare that they have no competing interests.
###end p 36
###begin title 37
Authors' contributions
###end title 37
###begin p 38
###xml 344 349 <span type="species:ncbi:9606">human</span>
SK carried out the molecular analyses, participated in the data analysis and interpretation, and drafted the manuscript, SMW participated in the design of the study, in the data analysis and interpretation, performed the statistical analysis, and contributed to manuscript writing, YPY and PB did the bioinformatic analysis and established the human cMNR database and the list of candidate genes, MvKD provided project supervision, JG provided the general concept, design of study, supervision and contributed to manuscript writing.
###end p 38
###begin p 39
All authors read and approved the final manuscript.
###end p 39
###begin title 40
Note
###end title 40
###begin p 41
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Table 1</bold>
###xml 9 77 9 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Coding microsatellites in candidate PTP genes examined in this study</bold>
Table 1: Coding microsatellites in candidate PTP genes examined in this study.
###end p 41
###begin p 42
For each of the 16 PTPs is given the official HUGO identification (hugoID), the actual Ensembl entry ID at  (ENSG), the chromosomal localization (Chr.), the former EMBL accession number (Acc. no.), the type of tract (nucleotide and length, cMNR), the exact position of the tract in relation to the sequence of the EMBL entry (Pos.), the annealing temperature for PCR (Ta) as well as the primer sequences (5' -> 3', sense and antisense) used for fragment analysis of the respective tract.
###end p 42
###begin p 43
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Table 2</bold>
###xml 9 75 9 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Allelic cMNR mutation status in MSI-H colorectal cancer cell lines</bold>
Table 2: Allelic cMNR mutation status in MSI-H colorectal cancer cell lines.
###end p 43
###begin p 44
Wild type: wt; Deletions of one or two mononucleotides: -1, -2; Insertions of one or two mononucleotides: +1, +2; Analysis failed or not evaluable: 0.
###end p 44
###begin p 45
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Table 3</bold>
###xml 9 68 9 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Allelic cMNR mutation status in MSI-H colorectal carcinomas</bold>
Table 3: Allelic cMNR mutation status in MSI-H colorectal carcinomas.
###end p 45
###begin p 46
For abbreviations see legend of Table 2.
###end p 46
###begin p 47
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Table 4</bold>
###xml 9 99 9 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PTP cMNR mutation frequencies in MSI-H colorectal cancer cell lines, tumors, and adenomas*</bold>
Table 4: PTP cMNR mutation frequencies in MSI-H colorectal cancer cell lines, tumors, and adenomas*.
###end p 47
###begin p 48
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN21</italic>
*Analysis restricted to PTPN21.
###end p 48
###begin title 49
Pre-publication history
###end title 49
###begin p 50
The pre-publication history for this paper can be accessed here:
###end p 50
###begin p 51

###end p 51
###begin title 52
Supplementary Material
###end title 52
###begin title 53
Additional file 1
###end title 53
###begin p 54
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplemental material and results information.</bold>
Supplemental material and results information. Table 1 shows the PTP candidate list including primer systems used for the fragment analysis, Tables 2 and 3 present cMNR mutation status information in MSI-H colorectal cancer cell lines and tumors, and Table 4 summarizes the mutation frequencies of the PTP candidate genes in MSI-H colorectal cancer cell lines, tumors, and adenomas.
###end p 54
###begin p 55
Click here for file
###end p 55
###begin title 56
Acknowledgements
###end title 56
###begin p 57
We gratefully acknowledge the excellent technical assistance of B. Kuchenbuch and G. Russell. This work was supported by the Deutsche Krebshilfe (M.v.K.D.; J.G.), DFG and BMBF (P.B.).
###end p 57
###begin article-title 58
Increased p53 protein content of colorectal tumours correlates with poor survival
###end article-title 58
###begin article-title 59
Allelic loss of chromosome 18q and prognosis in colorectal cancer
###end article-title 59
###begin article-title 60
Survival and acquired genetic alterations in colorectal cancer
###end article-title 60
###begin article-title 61
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
###end article-title 61
###begin article-title 62
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management
###end article-title 62
###begin article-title 63
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
###end article-title 63
###begin article-title 64
Microsatellite instability in cancer of the proximal colon
###end article-title 64
###begin article-title 65
Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens
###end article-title 65
###begin article-title 66
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
###end article-title 66
###begin article-title 67
Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene
###end article-title 67
###begin article-title 68
Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells
###end article-title 68
###begin article-title 69
Variable mutation frequencies in coding repeats of TCF-4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability
###end article-title 69
###begin article-title 70
Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability
###end article-title 70
###begin article-title 71
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability
###end article-title 71
###begin article-title 72
Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells
###end article-title 72
###begin article-title 73
Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes
###end article-title 73
###begin article-title 74
###xml 106 111 <span type="species:ncbi:9606">human</span>
Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas
###end article-title 74
###begin article-title 75
Evidence of Selection for Clones Having Genetic Inactivation of the Activin A Type II Receptor (ACVR2) Gene in Gastrointestinal Cancers
###end article-title 75
###begin article-title 76
Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution
###end article-title 76
###begin article-title 77
TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription
###end article-title 77
###begin article-title 78
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
###end article-title 78
###begin article-title 79
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
###end article-title 79
###begin article-title 80
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
###end article-title 80
###begin article-title 81
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer
###end article-title 81
###begin article-title 82
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
###end article-title 82
###begin article-title 83
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
###end article-title 83
###begin article-title 84
Combinatorial control of the specificity of protein tyrosine phosphatases
###end article-title 84
###begin article-title 85
Oncogenic kinase signalling
###end article-title 85
###begin article-title 86
Signaling mutations and autoimmunity
###end article-title 86
###begin article-title 87
Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas
###end article-title 87
###begin article-title 88
###xml 79 84 <span type="species:ncbi:9606">human</span>
Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers
###end article-title 88
###begin article-title 89
A phosphatase associated with metastasis of colorectal cancer
###end article-title 89
###begin article-title 90
Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization
###end article-title 90
###begin article-title 91
Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers
###end article-title 91
###begin article-title 92
###xml 75 80 <span type="species:ncbi:9606">human</span>
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
###end article-title 92
###begin article-title 93
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers
###end article-title 93
###begin article-title 94
Mutational analysis of the tyrosine phosphatome in colorectal cancers
###end article-title 94
###begin article-title 95
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system
###end article-title 95
###begin article-title 96
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer
###end article-title 96
###begin article-title 97
Microsatellite instability of selective target genes in HNPCC-associated colon adenomas
###end article-title 97
###begin article-title 98
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human colonic adenocarcinoma cells. I. Establishment and description of a new line
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human colon adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro
###end article-title 99
###begin article-title 100
Screening for microsatellite instability target genes in colorectal cancers
###end article-title 100
###begin article-title 101
Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype
###end article-title 101
###begin article-title 102
Protein tyrosine phosphatases: from genes, to function, to disease
###end article-title 102
###begin article-title 103
Cancer biology. A matter of dosage
###end article-title 103
###begin article-title 104
Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way
###end article-title 104
###begin article-title 105
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases
###end article-title 105
###begin article-title 106
Protein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinases
###end article-title 106
###begin article-title 107
Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling
###end article-title 107
###begin article-title 108
###xml 23 28 <span type="species:ncbi:9606">human</span>
Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer
###end article-title 108

